1,966 hedge funds and large institutions have $146B invested in Pfizer in 2015 Q4 according to their latest regulatory filings, with 195 funds opening new positions, 799 increasing their positions, 755 reducing their positions, and 80 closing their positions.

New
Increased
Maintained
Reduced
Closed

more first-time investments, than exits

New positions opened: | Existing positions closed:

more funds holding

Funds holding:

more ownership

Funds ownership:

more repeat investments, than reductions

Existing positions increased: | Existing positions reduced:

4% more capital invested

Capital invested by funds: $140B → $146B (+$6.16B)

5% less funds holding in top 10

Funds holding in top 10: 267253 (-14)

39% less call options, than puts

Call options by funds: $1.79B | Put options by funds: $2.95B

Holders
1,966
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
253
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
$1.79B
Puts
$2.95B
Net Calls
Net Calls Change

Top Buyers

1 +$588M
2 +$433M
3 +$411M
4
CM
Corvex Management
New York
+$391M
5
Sanders Capital
Sanders Capital
Florida
+$331M

Top Sellers

1 -$1.43B
2 -$1.39B
3 -$1.31B
4
Franklin Resources
Franklin Resources
California
-$677M
5
Bank of New York Mellon
Bank of New York Mellon
New York
-$368M
Name Holding Trade Value Shares
Change
Change in
Stake
126
$182M
127
$180M
128
$179M
129
$178M
130
$175M
131
$169M
132
$159M
133
$157M
134
$155M
135
$153M
136
$152M
137
$150M
138
$149M
139
$149M
140
$147M
141
$146M
142
$144M
143
$144M
144
$143M
145
$143M
146
$142M
147
$139M
148
$138M
149
$136M
150
$135M